NCT05413720View on ClinicalTrials.gov

Study of the Innate Immune Response to the Acute Phase of Human Leptospirosis - IMMUNOLEPTO

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 6, 2021

Primary Completion Date

July 20, 2022

Study Completion Date

July 20, 2022

Conditions
Leptospirosis
Interventions
OTHER

two additional blood samples specific to research

proportion of activated monocyte cells (CD14+CD16+ phenotype) within monocytes in the acute phase

Trial Locations (4)

97400

CHU de la Réunion, Saint-Denis

97448

CHU de la Réunion, Saint-Pierre

97460

CHOR, Saint-Paul

97470

GHER, Saint-Benoît

All Listed Sponsors
lead

Centre Hospitalier Universitaire de la Réunion

OTHER

NCT05413720 - Study of the Innate Immune Response to the Acute Phase of Human Leptospirosis - IMMUNOLEPTO | Biotech Hunter | Biotech Hunter